Gritstone Bio Inc (GRTS)
0.5863
-0.07
(-10.13%)
USD |
NASDAQ |
Jul 01, 16:00
0.5863
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio Research and Development Expense (Annual): 127.18M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 127.18M |
| December 31, 2022 | 111.40M |
| December 31, 2021 | 97.49M |
| December 31, 2020 | 88.64M |
| Date | Value |
|---|---|
| December 31, 2019 | 82.90M |
| December 31, 2018 | 54.96M |
| December 31, 2017 | 35.69M |
| December 31, 2016 | 13.92M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
82.90M
Minimum
2019
127.18M
Maximum
2023
101.52M
Average
97.49M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Marinus Pharmaceuticals Inc | 99.39M |
| Petros Pharmaceuticals Inc | 2.409M |
| NovaBay Pharmaceuticals Inc | 0.068M |
| Palatin Technologies Inc | 22.63M |
| iBio Inc | 10.33M |